MedTrace Logo

The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease

NCT00121550 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 4372

Last updated 2016-08-11

No results posted yet for this study

Summary

A growing body of evidence links Chlamydia pneumoniae to the progression of coronary heart disease. The purpose of this study is to determine the positive and negative effect of 14 days treatment with clarithromycin 500 mg daily in patients already suffering from stable coronary heart disease. The participants will be followed for at least two years after the treatment.

Abbott Laboratories supplied Clarithromycin and placebo tablets.

Conditions

Interventions

DRUG

clarithromycin

Sponsors & Collaborators

  • Danish Heart Foundation

    collaborator OTHER

  • Copenhagen Hospital Corporation

    collaborator OTHER

  • The Danish Medical Research Council

    collaborator OTHER

  • The 1991 Pharmacy Foundation

    collaborator OTHER

  • Abbott

    collaborator INDUSTRY

  • Copenhagen Trial Unit, Center for Clinical Intervention Research

    lead OTHER

Principal Investigators

  • Christian Jespersen, DMSc · Department of Cardiology Y, Bispebjerg Hospital, Bispebjerg Bakke 23, DK 2400 Copenhagen NV, Denmark.

  • Christian Gluud, DMSc · Copenhagen Trial Unit, Center of Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100 Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
84 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-10-31
Primary Completion
2000-04-30
Completion
2002-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00121550 on ClinicalTrials.gov